4-(4-METHOXYPHENYL)PYRIDINE-2,6-DICARBOXYLIC ACID

Catalog No.: 
ACUWAT477
CAS No.: 
259228-52-9
Molecular Formula: 
C14H11NO5
Molecular Weight: 
273.24
4-(4-METHOXYPHENYL)PYRIDINE-2,6-DICARBOXYLIC ACID structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$94.00In stockInquiry
250mg95%$168.00In stockInquiry
1g95%$421.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-METHOXYPHENYL)PYRIDINE-2,6-DICARBOXYLIC ACID
IUPAC Name4-(4-methoxyphenyl)pyridine-2,6-dicarboxylic acid
MDL No.MFCD31652957
Molecular FormulaC14H11NO5
Molecular Weight273.24
SMILESOC(C1=NC(C(O)=O)=CC(C2=CC=C(C=C2)OC)=C1)=O
InChI KeyDTHXIXSONWAIPQ-UHFFFAOYSA-N
Synonym4-(4-Methoxyphenyl)pyridine-2,6-dicarboxylic acid;2,6-Pyridinedicarboxylic acid, 4-(4-methoxyphenyl)-
CAS No.259228-52-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUWAT477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPSA972 route compound structure diagram
    ACFPSA9725720-07-0In Stock
  2. Plus
  3. ACJMFY957 route compound structure diagram
    ACJMFY9574722-94-5In Stock
  4. Then
  5. ACUWAT477 route product structure diagram
    ACUWAT477259228-52-9In Stock
Inquiry

2. ACUWAT477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUWAT477 route product structure diagram
    ACUWAT477259228-52-9In Stock
Inquiry

3. ACUWAT477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUWAT477 route product structure diagram
    ACUWAT477259228-52-9In Stock
Inquiry

Comments (0)